Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
HER2 Expression in Urothelial Carcinoma (UC)
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Hospital Benin, Congo, The Democratic Republic
Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate Vaccination
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid Arthritis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
2025 Rheumatology Fellowship – United States
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Invasive Mold Diseases (IMD) & Treatment Outcomes
Release Date:
Review Process: Pfizer Internal
Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom
Implementing Updated RSV Immunization Recommendations for Older Adults
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Optimization of Health IT to support RSV Immunizations
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines USA
Title
Grant Type
Focus Area
Country
Application Due Date
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
PCF-Pfizer Health Equity Challenge Awards
Release Date:
Partner: Prostate Cancer Foundation
Review Process: Expert Review Panel
Research Oncology All
Shared Decision Making Including Financial Cost and Cancer Treatment
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Employment Support / Lung Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Biomarker Testing / Lung Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Epidemiology of Atopic Dermatitis, Alopecia Areata and Vitiligo Needs Assessment (Asia, Latin America, the Middle East & Africa)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
Early Identification and Diagnosis of Axial Spondyloarthritis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
BRAF-mutant melanoma: treatment selection and side effect management
Release Date:
Review Process: Pfizer Internal
Education Oncology Canada, USA
Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic Embolism
Release Date:
Review Process: Expert Review Panel
Quality Improvement Internal Medicine Japan
Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan